Background As part of a comprehensive nonsurgical approach, epidural injections often are used in the management of lumbar disc herniation. Recent guidelines and systematic reviews have reached different conclusions about the efficacy of epidural injections in managing lumbar disc herniation. Questions/purposes In this systematic review, we determined the efficacy (pain relief and functional improvement) of the three anatomic approaches (caudal, lumbar interlaminar, and transforaminal) for epidural injections in the treatment of disc herniation.
Introduction
Epidural injections are one of the most common nonsurgical treatments for lumbar disc herniation [8, 22, 69, 71, 100, 103, 119] . Epidural injections are administered by accessing the lumbar epidural space by multiple routescaudal, transforaminal, and interlaminar [1, 7, 8, 17, 21, 22, 69, 71, 100, 103, 119] . Even though all three modalities deliver medication into the epidural space, there are important differences among the approaches. The interlaminar entry is considered to deliver the medication close to the assumed site of pathology, but the transforaminal approach is considered the target-specific modality requiring the smallest volume to reach the primary site of pathology. In contrast, caudal epidurals are considered the safest and easiest, with minimal risk of inadvertent dural puncture, and are the preferred modality in postsurgery syndrome, even though they require relatively high volumes and have an alleged lack of specificity to the assumed site of pathology. Consequently, therapeutic effectiveness also varies among the three approaches [8, 69, 71, 100] .
Numerous systematic reviews and guidelines performed by various groups of authors have reached different conclusions about the level of evidence for the effectiveness of epidural injections [5, 7, 8, 21-23, 31, 66, 69, 71, 79, 100, 103, 105, 106, 109, 113, 119] . Some authors have concluded against the effectiveness and medical necessity of epidural injections in managing pain and improving function in patients with disc herniation and radiculitis [5, 21-23, 103, 119] ; however, these have been challenged [69, 76] , with multiple trials showing significant improvement in pain and function [7, 8, 31, 66, 69, 71, 100, 106, 109, 113] . Some of these systematic reviews and the trials included were criticized for flaws in the assessment of trials, combining trials with variable designs, and designating active controlled trials as placebo control [22, 35, 45, 69, 70, 103, 119] . A recent systematic review by Pinto et al. [103] analyzed all epidural injection approaches compared with a placebo in patients with sciatica, offered criticism of the past reviews and guidelines [7, 8, 70, 72, 100] , and criticized some reviews [5, 21, 23, 31] for summarizing the evidence from placebo-controlled trials without considering the size of the treatment effect. Pinto et al. [103] have concluded that there was high-quality evidence showing that epidural steroid injections have small, short-term effects on leg pain and disability compared with placebo in patients with sciatica but no effect in the long term. However, this systematic review by Pinto et al. [103] also had multiple deficiencies [65, 67] . Since the systematic review by Pinto et al. [103] was based on a methodologic rather than a clinical perspective [78, 80] , which we find challenging, our review focused on the clinical aspects with appropriate methodologic quality assessment.
Thus, in this systematic review, we determined the short-and long-term efficacy (pain relief and functional improvement) of the three anatomic approaches (caudal, lumbar interlaminar, and transforaminal) for epidural injections in the treatment of disc herniation, considering only placebo-controlled and active-controlled trials.
Materials and Methods

Search Strategy and Criteria
We performed a literature search from 1966 to June 2013 utilizing data from PubMed, Cochrane library, US National Guideline Clearinghouse, previous systematic reviews, and cross-references. The search strategy emphasized low-back and lower-extremity pain, disc herniation, and radiculitis treated with caudal, interlaminar, or transforaminal epidural injections. Search terms included chronic low-back pain, lower-extremity pain, disc herniation, nerve root compression, radiculitis, epidural injections, caudal, interlaminar, and transforaminal.
Study selection was achieved as recommended by Preferring Reporting Items for Systematic Reviews and MetaAnalyses [64] (Fig. 1) . We reviewed all studies providing appropriate management and with outcome evaluations of 3 months or longer and statistical evaluations. Only randomized controlled trials (RCTs) were included for analysis, either placebo or active controlled. The true definition of placebo is to inject an inactive substance into an inactive structure; for the purposes of this review, we have utilized an injection of placebo into the epidural space or over the nerve root by any approach as placebo [48, 49, 54, 82] . The duration of symptoms of the study participants was classified as subacute (6-12 weeks) and chronic ([ 12 weeks). For this evaluation, only the studies utilizing patients with chronic symptoms or patients with a mixture of subacute and chronic symptoms were considered. Studies including radiculitis secondary to spinal canal or foraminal stenosis, postsurgery syndrome, or disc herniation in postsurgery syndrome and chemical radiculitis were not included in this review. However, trials with the inclusion of multiple groups of patients were included if they had at least 25 patients with disc herniation in each group.
Overall, there were 66 RCTs for consideration. As we wanted to include only RCTs of high or moderate quality for analysis, we assessed the methodologic quality of these 66 studies using the Cochrane review criteria for RCTs [35] . The criteria include assessment of adequate randomization, treatment allocation concealment, appropriate blinding, description of incomplete outcome data with dropouts and intent-to-treat analysis, study being free of suggestions of selective outcome reporting, and other sources of potential bias including baseline characteristics, cointerventions, compliance, and timing of the outcome measurements in all groups. The methodologic quality was graded as high if nine to 12 criteria were fulfilled, moderate Lee et al. [63] (Table 2) were of high quality.
We graded the evidence for each approach using five levels of best evidence synthesis, which summarized the results according to the Cochrane rating system based on the quality and the outcome of the studies [119] . The levels of evidence were distinguished as follows: (1) strong evidence: consistent findings among multiple high-quality RCTs; (2) moderate evidence: consistent findings among multiple low-quality RCTs or one high-quality RCT; (3) limited evidence: one low-quality RCT; (4) conflicting evidence: inconsistent findings among multiple trials; and (5) no evidence: no RCTs. The evidence of all three approaches for epidural injections was strong for the short term and moderate for the long term. Further, the results were considered consistent if 60% of the trials showed results in the same direction.
At least two of the review authors (RMB, FJEF) independently, in an unblinded standardized manner, performed each search and methodologic quality assessment. The primary authors of manuscripts were not involved in the methodologic quality assessment. All searches were combined to obtain a unified strategy. Any disagreements between reviewers were resolved by a third author (JAH) and consensus.
Outcome Measures
The primary outcome measure was pain relief, defined as 50% or more reduction in pain or at least a 3-point decrease in pain scores in at least 50% of patients. The secondary outcome measure was functional improvement, defined as 50% reduction in disability or 30% reduction in the disability scores.
The injection therapy was considered effective, either with a placebo control or active control, if there was a difference in effect for the primary outcome measure in a statistically significant manner at the 5% level. Outcomes Table 2 . were considered at 3 months, 6 months, and 1 year and in the short term (\ 6 months) and long term (C 6 months). Meta-analysis was considered if more than two RCTs were homogeneous for mode of administration. However, we found that there was insufficient homogeneity for metaanalysis.
Results
Four of five total trials (three fluoroscopic, two nonfluoroscopic) and all three fluoroscopic trials showed efficacy of caudal epidural injections in managing lumbar disc herniation, with strong evidence in the short and moderate evidence for the long term ( Table 3 ). The three fluoroscopic trials [1, 29, 86] included two high-quality trials [29, 86] and one moderate-quality trial showing mid-term efficacy [1] . Of the nonfluroroscopic trials, one moderatequality nonfluoroscopic trial [95] showed efficacy and one moderate-quality ultrasound trial did not [50] .
Five fluoroscopic trials [1, 3, 63, 89, 107] showed efficacy of lumbar interlaminar epidural injections in managing lumbar disc herniation, with strong evidence for the short term and moderate evidence [3, 89] for the long term. Two of these trials were high quality [3, 89] and three moderate quality [1, 63, 107] (Table 4) . Of the four nonfluoroscopic studies (all high quality), two showed efficacy [104, 128] and two did not [4, 18] . However, the level of evidence was strong and moderate based on fluoroscopic trials only, whereas a combination of fluoroscopic and nonfluoroscopic trials yielded moderate evidence, and when only nonfluoroscopic or blind trials were considered, the evidence was conflicting, with inconsistent findings among multiple trials.
Seven fluoroscopic trials showed efficacy of transforaminal epidural injections in managing lumbar disc herniation, with strong evidence for the short term and moderate evidence for the long term (Table 5 ). Three of these were high-quality trials [40, 51, 121] and four moderate-quality trials [1, 97, 107, 112] . Two high-quality fluoroscopic trials showed lack of efficacy [25, 55] .
Discussion
Lumbar disc herniation is readily diagnosed and the most common indication for surgical intervention in the lumbar spine [43, 127] . While it is generally believed that the course and prognosis of acute sciatica secondary to disc herniation are favorable [59, 125] , some patients continue to have persistent and disabling symptoms for 2 years or longer [34, 123] and many undergo surgery [43, 117, 127] . Therapeutic epidural injections utilized as a nonsurgical management for chronic persistent disabling disc herniation and radiculitis have become increasingly popular [46, 81, 83, 84] . In fact, Manchikanti et al. [83] , in an assessment of utilization characteristics of epidural injections in the fee-for-service Medicare population, found a 130% growth per 100,000 Medicare patients from 2000 to 2011 [81, 83, 84] . The lumbar transforaminal approach had a breathtaking increase of 665% in that same period. In this systematic review, we determined the efficacy of the three anatomic approaches to epidural injections-caudal, lumbar interlaminar, and transforaminal-in the treatment of disc herniation and radiculitis with placebo-controlled and active-controlled interventions.
The limitations of this review include the paucity of high-quality literature for each modality, despite 23 trials meeting inclusion criteria in lumbar disc herniation for three modes of administration. In addition, we were unable to perform a meta-analysis due to a lack of homogeneity among the RCTs for mode of administration. Further, the majority of the evidence was obtained from active-controlled trials, specifically for long-term improvement with all three approaches. Active-controlled trials compare two different procedures or drugs. Thus, some may consider this as a weakness. The majority of the analytical flaws arrive as methodologists consider one of the drugs as placebo and compare between the two groups rather than baseline to followup periods. Thus, the strengths of activecontrolled trials include their comparative evaluation, which has become pivotal in modern evidence-based medicine [77] . These studies provide insight into the effectiveness of local anesthetic with or without steroids and various methods such as interlaminar, caudal, and transforaminal. Placebo-controlled trials are also extremely important and constitute a limitation to our analysis. Specifically, it is desirable to have studies with their placebo group designed with appropriate inclusion of injection of placebo solution into a nonactive structure, which has not been included in the majority of the studies and is a debated issue [9, 10, 18-20, 40, 50, 55, 69, 70, 78, 103] . Further, placebo interventions have been misinterpreted based on the solution injected and the location of the injection. This has reached such proportions that methodologists have continued to consider even a local anesthetic injection or any solution injected into an active structure as placebo even though these invariably result in a multitude of effects, with some of the effects being therapeutic [6, 8-10, 18, 19, 33, 40, 48, 50, 54, 55, 62, 70, 71, 73-75, 78, 80, 86-91, 100-103, 115, 120] . In designing the studies, apart from active-controlled design, the reviewers must be cognizant of the multiple effects of placebo; nocebo; Hawthorne effect; natural course of the disease, which is not applicable in these chronic patients; and regression to the mean, which has been extensively discussed in Table 3 . was not a true placebo study. Even though there was no significant difference, the authors concluded epidural steroid injections may provide short-term pain relief for some. The included patients had subacute sciatica.
Ghahreman et al. [40] Table 5 . reference to placebo, nocebo, and pure and impure placebos [48, 54] . Thus, this may be considered as a weakness but not a flaw unless active-controlled trials are misinterpreted. Some may also consider not utilizing all RCTs irrespective of their size and quality as a deficiency; however, we believe that is one of the strengths of this systematic review. We found high-quality evidence showing that epidural injections have short-term benefits in terms of alleviating pain and disability of lumbar disc herniation and moderate long-term effects for all three approaches. The evidence was stronger for short-term effects compared to long-term effects. The results of our systematic review are similar to those of some previous reviews [8, 69, 71, 76, 100] . Of importance is the systematic review by Pinto et al. [103] , which partially agreed with our review in reference to short-term but not long-term improvement. Pinto et al. [103] concluded epidural steroid injections have a small, short-term effect on leg pain and disability compared to placebo in patients with sciatica, but without significant effect in the long term. Our review differs from that of Pinto et al. [103] , which has been criticized for its deficiencies [65, 67] . Pinto et al. [103] utilized methodologic quality assessment criteria, based on an instrument developed for physiotherapy, which has not been validated for interventional techniques [65, 67] and differs substantially from criteria developed by the Cochrane review group [35, 119] . Additional deficiencies of that systematic review include the inclusion of a multitude of heterogeneous studies that were labeled homogeneous. The authors indicated that the studies were homogeneous based on the fact that reviewers have decided that local anesthetic injection was a placebo. We believe that such a methodology invalidates the entire concept of meta-analysis of homogeneous studies. Pinto et al. [103] also did not take into consideration the varying effects of placebo and nocebo, impure placebo, and the effects of injecting not only various active solutions but also inactive solutions into active structures [20, 48, 49, 54, 69-71, 78, 82] .
The evidence appears to be somewhat stronger for caudal epidural injections. Only one placebo-controlled trial by Iversen et al. [50] utilizing ultrasound imaging showed a lack of efficacy. However, this trial has numerous deficiencies, including flawed design, poor selection criteria, poor inclusion criteria, and no injection of local anesthetic, leading to only moderate quality in methodologic quality assessment. The only study assessing longterm improvement of 2 years, including 120 patients with local anesthetic with or without steroids, was an activecontrolled trial that showed sustained improvement over a 2-year period, with repeat procedures as medically necessary and indicated, both in reducing low-back and lowerextremity pain and improving function [79, 85, 86] . For lumbar interlaminar epidural injections, there were two fluoroscopic studies [3, 89] and one blind trial [104] assessing long-term effectiveness that showed improvement. A major study by Carette et al. [18] , published in 1997, showed no efficacy with a blind approach. In this assessment, the authors utilized sodium chloride solution in the epidural space, which may have significant effects beyond the placebo effect [8, 9, 44, 71, 82, 85, 86, 89, 91, 100, 129] . Of the trials showing improvement, all were actively controlled [3, 89, 104] . However, true placebo studies with injection into the intraspinous ligament showed contradicting results. Efficacy was shown by Dilke et al. [32] in 1973 and lack of efficacy was shown by Arden et al. [4] in 2005.
In reference to lumbar transforaminal epidural injections, there was only one long-term study with 1-year followup in a relatively small number of patients (total 55) with an active-controlled design. There were multiple wellperformed studies showing no efficacy. Among the placebo studies [25, 40, 55] , Ghahreman et al. [40] used a true placebo design injecting sodium chloride solution into a muscle and over the nerve root, whereas Cohen et al. [25] and Karppinen et al. [55] utilized a rather impure placebo design injecting sodium chloride solution into the neural space over the nerve root.
There was only one trial, that of Ackerman and Ahmad [1] , comparing all three approaches; however, this was only of moderate quality and reported improvement with a 6-month followup, with superior results for the transforaminal approach compared to the interlaminar and caudal approaches. One additional trial by Lee et al. [63] compared interlaminar versus transforaminal epidural injection with a short-term followup and showed basically similar results with both approaches.
In this analysis, utilizing appropriate methodology, based on Cochrane review criteria for quality of evidence for RCTs [119] , we found strong evidence for epidural injections in managing chronic pain of disc herniation in the short term and moderate evidence in the long term. This may be in contrast to some of the previous reviews while in agreement with others. Previous authors have concluded lack of efficacy of epidural injections over the long term, inappropriately utilized local anesthetic as placebo, and performed meta-analysis that often yielded misleading results because local anesthetics have yielded results that were similar to steroids [22, 69, 78, 86, 91, 103, 119] . While the strength of our review is that it provided qualitative evidence, we were unable to provide quantitative information (as might be done through pooling data in meta-analysis) because of excessive heterogeneity among the trials identified by the systematic review. Thus, to facilitate meta-analysis, future RCTs should focus on study design with long-term followup and appropriate outcome parameters, which will make it more likely that their results will be suitable for pooling and make them more likely to be included in a meta-analysis. These results can guide shared decision making in which patients are informed about up-to-date evidence and probable outcomes in a balanced manner [26] .
